Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Flying Under the Radar with a Possible COVID-19 Treatment

Investors would think a pharmaceutical company heading into Phase 2b/3 human trials for treating the third most malignant disease after lung cancer and pancreatic cancer would draw eyes from major players. If that same company announced it was embarking on Phase2b/3 human tri...
Stockhouse Editorial | September 8, 2020 |

Lannett Signs Exclusive U.S. Distribution Deal with Sinotherapeutics; Shares Up 40%

Shares of Lannett Co. are up 40% today after announcing that it secured rights to be the exclusive U.S. distributor of Sinotherapeutics' antifungal drug that is an AB-rated generic for Noxafil. This morning generic drug maker Lannett Company Inc. (LCI:NYSE.MKT) anno...
Streetwise Reports | August 29, 2019 |

Accelerating the Business of Agriculture and Agri-tech

Getting food to table on a massive scale is, pardon the pun, no small potatoes. It’s a huge, complicated operational machine that requires a myriad of logistical, technical, and technological parts to keep it moving smoothly. In this lively and informati...
Dave Jackson | May 4, 2020 |

A True Disruptive Technology that Leverages the Power of Analytics

When Stockhouse Editorial first introduced our audience to Visionstate Corp. ( TSX-V: VIS , OTC: VSSSF , Forum ) back in May , we learned about a company so unique that their Internet of Things platform has, essentially, no direct competition in the marketplace. Vision...
Dave Jackson | January 14, 2022 |

Puma Biotech Shares Up More Than 20% on Q2 Earnings and Breast Cancer Drug Sales

Shares in Puma Biotechnology are trading 20% higher today after the company released Q2/19 earnings and reported positive NERLYNX revenue growth. Biopharmaceutical company Puma Biotechnology Inc. (PBYI:NADSAQ) shares opened more than 20% higher to...
Streetwise Reports | August 14, 2019 |

Exelixis Shares Climb 21% on Positive Phase 3 Advanced Kidney Cancer Study Results

Shares of Exelixis reached a new 52-week high price after the firm reported positive topline results from its Pivotal Phase 3 CheckMate -9ER trial evaluating Opdivo® (nivolumab) in combination with CABOMETYX® (cabozantinib) in previously untreated advanced ...
Streetwise Reports | April 21, 2020 |

Visionstate continues to launch WANDA in new markets

TMH: Visionstate is a growth-oriented company investing primarily in the Internet of Things, big data and analytics, and sustainability. The Edmonton-based tech firm’s proprietary smart technology now extends to a range of public facilities across a...
Brieanna McCutcheon | May 18, 2023 |

BIGG Digital Assets, NetCents, Northern Data - who is the best blockchain pearl?

The Blockchain phenomenon has kept the world in a state of excitement in the second half of 2017. A revolution by many young entrepreneurs and investors seemed to be on the way. Business models were springing up like mushrooms. There were almost no barriers to market entry, as...
Mario Hose | July 17, 2020 |

Q1 GDP Data Masking The True Global Economic Future?

As Q1 GDP data is released on Wednesday, April 29, which will reflect the first three months of 2020 in terms of total economic output, we believe the number will skew the current true global economic conditions to a large degree. The pandemic shutdowns started in the US on ...
Chris Vermeulen | April 29, 2020 |

Micro-Cap Pharma Moving Ahead with Plans for Phase 3 US Trial of a Repurposed Drug for Covid-19

Revive Therapeutics is focused on infectious diseases as well as treatments using psilocybin-based formulations. Revive Therapeutics Ltd. (RVV:TSX.V; RVVTF:OTCMKTS) , a company that focuses on repurposing drugs for infectious diseases and rare disorders, is prepari...
Streetwise Reports | June 4, 2020 |
1 2 3 4 5 6 7